AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

LEVAMISOLE +OXYCLOZANIDE

13 registrations across 3 African markets— 12 active

Markets with LEVAMISOLE +OXYCLOZANIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
NILZAN BOLUS
TABLET; ORAL
🇿🇼ZimbabweINTERVET S.A (PTY) LTDactiveDec 2027
LEVAFAS X-TRA
ORAL LIQUID ORDINARY SUSPENSIONS
🇺🇬UgandaNORBROOK KENYA LTDexpiredJul 2014
Levafas Diamond Fluke and Worm Drench
Suspension, Oral
🇹🇿TanzaniaNorbrook kenya Limitedactive
Nilfarm Gold
Suspension, Oral
🇹🇿TanzaniaFARMERS CENTRE LTDactive
Nilfarm Suspension
Suspension, Oral
🇹🇿TanzaniaFARMERS CENTRE LTDactive
WORMIFAS DRENCH
Oral Suspension
🇹🇿TanzaniaVETCARE KENYA LIMITEDactive
Nilzash S Forte
Suspension, Oral
🇹🇿TanzaniaAshish Life Science Pvt Limitedactive
Wormifas Mzito
Oral Suspension
🇹🇿TanzaniaVETCARE KENYA LIMITEDactive
Levafas Xtra Fluke & Worm Drench
Suspension, Oral
🇹🇿TanzaniaNorbrook kenya Limitedactive
NILVASOL SUSPENSION🇹🇿TanzaniaMEDISEL (KENYA) LIMITEDactive
Nilzash
Bolus
🇹🇿TanzaniaAshish Life Science Pvt Limitedactive
Baoxle
Suspension, Oral
🇹🇿TanzaniaBAJUTA INTERNATIONAL (T) LTDactive
Zanide Forte
Oral Suspension
🇹🇿TanzaniaMEDMAC FOR MANUFACTURING AGRICULTURAL CHEMICALS AND VETERINARY PRODUCTS LIMITEDactive

LEVAMISOLE +OXYCLOZANIDE in Africa — Regulatory Overview

LEVAMISOLE +OXYCLOZANIDE is registered across 3 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Uganda, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.

Of the 13 registrations, 12 (92%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.